Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1

Animal models are essential to study novel antiretroviral drugs, resistance-associated mutations (RAMs), and treatment strategies. Bictegravir (BIC) is a novel potent integrase strand transfer inhibitor (INSTI) that has shown promising results against HIV-1 infection in vitro and in vivo and against...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Hassounah, Said A., Alikhani, Ahmad, Oliveira, Maureen, Bharaj, Simrat, Ibanescu, Ruxandra-Ilinca, Osman, Nathan, Xu, Hong-Tao, Brenner, Bluma G., Mesplède, Thibault, Wainberg, Mark A.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700299/
https://ncbi.nlm.nih.gov/pubmed/28923862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01695-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars